The EHA2021 Virtual Congress will take place on June 9–17 and will remain accessible until August 15, 2021. EHA continues to dedicate its efforts to guiding hematologists in both clinical and research settings. Although face-to-face interactions are an important aspect of any congress, the current pandemic severely limits the possibilities. A core objective of EHA is …

Welcome to EHA2021 Virtual Congress Read More »

Our team at SOPHiA GENETICS continues to work to help advance the efforts of SARS-CoV-2 surveillance and research. During the first stages of the pandemic, we leveraged our experience in NGS and developed a robust solution for full-genome analysis of SARS-CoV-2 to identify circulating and emerging strains. Recently, our genomic experts have worked with international partners …

Mutational hotspot in the SARS-CoV-2 Spike protein N-terminal domain conferring immune escape potential Read More »

More than six people die every hour in the US from a blood cancer. Solutions can’t come fast enough for those who suffer with these cancers all around the world. Fortunately, researchers studying blood diseases have experienced rapid advances in their capabilities to develop and test effective therapies with some extremely significant advancements. READ MORE

More than 1.2 million people worldwide were diagnosed with blood cancer in 2020.1 Accurately identifying molecular alterations within the extensively heterogeneous landscape of blood cancer disorders can contribute to improved prognosis and disease management. READ MORE